New patent for Boehringer Ingelheim drug TRADJENTA

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post New patent for Boehringer Ingelheim drug TRADJENTA appe…


New patent for Amicus Theraps drug GALAFOLD

Annual Drug Patent Expirations for GALAFOLD Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are twenty-five patents protecting this drug. This drug…
The post New patent for Amicus Theraps drug GALAFOLD appeared first …


Biotechblog